High Dose Therapy and Peripheral Blood Stem Cell Transplantation in HIV Related Non Hodgkin Lymphoma (NHL) at High Risk (HDT-HIV)

This study is currently recruiting participants.
Verified January 2012 by Azienda Ospedaliera Spedali Civili di Brescia
Sponsor:
Information provided by (Responsible Party):
Giuseppe Rossi, Azienda Ospedaliera Spedali Civili di Brescia
ClinicalTrials.gov Identifier:
NCT01045889
First received: January 8, 2010
Last updated: January 23, 2012
Last verified: January 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2014
  Estimated Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)